Clinical Trials Browser

Phase 1 × Adenocarcinoma × STA 9090 × Clear all

NCT01579994 2020-12-30

Crizotinib and Ganetespib (STA-9090) in ALK Positive Lung Cancers

Phase 1 Completed

Adenocarcinoma, Neoplasm Metastasis